<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.0 20040830//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">09-PONE-RA-12256R1</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0008710</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Cell Biology/Cell Growth and Division</subject><subject>Gastroenterology and Hepatology/Hepatology</subject><subject>Surgery/Gastrointestinal Surgery</subject></subj-group></article-categories><title-group><article-title>Mice Lacking Thyroid Hormone Receptor &#x003b2; Show Enhanced Apoptosis and Delayed Liver Commitment for Proliferation after Partial Hepatectomy</article-title><alt-title alt-title-type="running-head">Impaired Regeneration in TR-KO</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>L&#x000f3;pez-Fontal</surname><given-names>Raquel</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Zeini</surname><given-names>Miriam</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Trav&#x000e9;s</surname><given-names>Paqui G.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>G&#x000f3;mez-Ferrer&#x000ed;a</surname><given-names>Mariana</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Aranda</surname><given-names>Ana</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>S&#x000e1;ez</surname><given-names>Guillermo T.</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Cerd&#x000e1;</surname><given-names>Concha</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Mart&#x000ed;n-Sanz</surname><given-names>Paloma</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Hortelano</surname><given-names>Sonsoles</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Bosc&#x000e1;</surname><given-names>Lisardo</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain</addr-line></aff><aff id="aff2"><label>2</label><addr-line>Instituto de Investigaciones Biom&#x000e9;dicas &#x02018;Alberto Sols&#x02019; (CSIC-UAM), Madrid, Spain</addr-line></aff><aff id="aff3"><label>3</label><addr-line>Departamento de Bioqu&#x000ed;mica y Biolog&#x000ed;a Molecular-Servicio de An&#x000e1;lisis Cl&#x000ed;nicos, Hospital General Universitario, Valencia, Spain</addr-line></aff><aff id="aff4"><label>4</label><addr-line>Centro de Investigaci&#x000f3;n Biom&#x000e9;dica en Red de Enfermedades Hep&#x000e1;ticas y Digestivas (Ciberehd), Barcelona, Spain</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Rojas</surname><given-names>Mauricio</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">Emory University, United States of America</aff><author-notes><corresp id="cor1">&#x0002a; E-mail: <email>lbosca@iib.uam.es</email> (LB); <email>shortelano@cnic.es</email> (SH)</corresp><fn fn-type="con"><p>Conceived and designed the experiments: SH LB. Performed the experiments: RLF MZ PGT GTS CC SH. Analyzed the data: PGT PMS SH LB. Contributed reagents/materials/analysis tools: MGF AA PMS. Wrote the paper: LB.</p></fn></author-notes><pub-date pub-type="collection"><year>2010</year></pub-date><pub-date pub-type="epub"><day>14</day><month>1</month><year>2010</year></pub-date><volume>5</volume><issue>1</issue><elocation-id>e8710</elocation-id><history><date date-type="received"><day>14</day><month>8</month><year>2009</year></date><date date-type="accepted"><day>22</day><month>12</month><year>2009</year></date></history><permissions><copyright-statement>Lopez-Fontal et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement></permissions><abstract><sec><title>Background</title><p>The role of thyroid hormones and their receptors (TR) during liver regeneration after partial hepatectomy (PH) was studied using genetic and pharmacologic approaches. Roles in liver regeneration have been suggested for T3, but there is no clear evidence distinguishing the contribution of increased amounts of T3 from the modulation by unoccupied TRs.</p></sec><sec><title>Methodology/Principal Findings</title><p>Mice lacking TR&#x003b1;1/TR&#x003b2; or TR&#x003b2; alone fully regenerated liver mass after PH, but showed delayed commitment to the initial round of hepatocyte proliferation and transient but intense apoptosis at 48h post-PH, affecting &#x0223c;30&#x00025; of the remaining hepatocytes. Pharmacologically induced hypothyroidism yielded similar results. Loss of TR activity was associated with enhanced nitrosative stress in the liver remnant, due to an increase in the activity of the nitric oxide synthase (NOS) 2 and 3, caused by a transient decrease in the concentration of asymmetric dimethylarginine (ADMA), a potent NOS inhibitor. This decrease in the ADMA levels was due to the presence of a higher activity of dimethylarginineaminohydrolase-1 (DDAH-1) in the regenerating liver of animals lacking TR&#x003b1;1/TR&#x003b2; or TR&#x003b2;. DDAH-1 expression and activity was paralleled by the activity of FXR, a transcription factor involved in liver regeneration and up-regulated in the absence of TR.</p></sec><sec><title>Conclusions/Significance</title><p>We report that TRs are not required for liver regeneration; however, hypothyroid mice and TR&#x003b2;&#x02013; or TR&#x003b1;1/TR&#x003b2;&#x02013;deficient mice exhibit a delay in the restoration of liver mass, suggesting a specific role for TR&#x003b2; in liver regeneration. Altered regenerative responses are related with a delay in the expression of cyclins D1 and E, and the occurrence of liver apoptosis in the absence of activated TR&#x003b2; that can be prevented by administration of NOS inhibitors. Taken together, these results indicate that TR&#x003b2; contributes significantly to the rapid initial round of hepatocyte proliferation following PH, and improves the survival of the regenerating liver at later times.</p></sec></abstract><counts><page-count count="10"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Liver regeneration after removal of two-thirds of the organ (2/3 PH) is a well-known tissue repair process providing an example of a synchronized biological regenerative response. Much knowledge on liver regeneration has been obtained in recent years, and this process is known to involve the concerted action of hormones, growth factors and other metabolic stimuli <xref ref-type="bibr" rid="pone.0008710-Michalopoulos1">&#x0005b;1&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008710-Fausto1">&#x0005b;2&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008710-Fausto2">&#x0005b;3&#x0005d;</xref>. Roles in liver regeneration have been suggested for thyroid hormone (T3) and its receptors (TR), but there is no clear evidence distinguishing the contribution of increased amounts of T3 from the modulation by unoccupied thyroid hormone receptors (TRs), despite the fact that activated receptors have been recognized as important modulators of the regenerative response <xref ref-type="bibr" rid="pone.0008710-Alisi1">&#x0005b;4&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008710-FloresMorales1">&#x0005b;5&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008710-Pibiri1">&#x0005b;6&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008710-Kariv1">&#x0005b;7&#x0005d;</xref>. Recently, an induction of deiodinase type 3 (that catalyses the inactivation of T3 and T4) after PH has been described <xref ref-type="bibr" rid="pone.0008710-Kester1">&#x0005b;8&#x0005d;</xref>, which explains the transient drop of thyroid hormones described after PH by various groups (<xref ref-type="bibr" rid="pone.0008710-Alisi1">&#x0005b;4&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008710-Kester1">&#x0005b;8&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008710-Tien1">&#x0005b;9&#x0005d;</xref>, this work). Liver expresses both TR&#x003b1; and TR&#x003b2;, although their distribution and roles seem to depend on the developmental status of the animal: During the perinatal period, TR&#x003b1;1 plays a critical role in hepatocyte maturation, whereas in adult liver the predominant form is TR&#x003b2; <xref ref-type="bibr" rid="pone.0008710-Rodd1">&#x0005b;10&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008710-Schwartz1">&#x0005b;11&#x0005d;</xref>. However, TR&#x003b1; appears to be the predominant form of TR in the hepatocyte precursor, the stellate cells <xref ref-type="bibr" rid="pone.0008710-Kariv1">&#x0005b;7&#x0005d;</xref>.</p><p>The important role of T3 in regulating liver metabolism is well known. Gene profiling of livers from TR&#x003b2; knockout mice identified more than 200 differentially regulated genes, most down-regulated but others up-regulated, revealing a clear predominance of TR&#x003b2; over TR&#x003b1; in liver function <xref ref-type="bibr" rid="pone.0008710-FloresMorales1">&#x0005b;5&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008710-Yen1">&#x0005b;12&#x0005d;</xref>. Previous <italic>in vivo</italic> studies on the role of thyroid hormones in hepatocyte proliferation showed a proliferative action in combination with other mitogens, such as hepatocyte growth factor or keratinocyte growth factor. Indeed, in hypothyroid animals, liver regeneration after PH is associated with slower recovery of liver mass <xref ref-type="bibr" rid="pone.0008710-Alisi1">&#x0005b;4&#x0005d;</xref>, and studies of the liver proteome in rats showed that TR&#x003b2; is one of 34 proteins that are significantly upregulated in the regenerating liver after PH <xref ref-type="bibr" rid="pone.0008710-Sun1">&#x0005b;13&#x0005d;</xref>. A question emerging from these studies is how to distinguish between effects due to altered hormone activation of TRs and effects due to altered TR expression. We therefore investigated liver regeneration after PH in gene-deficient mice lacking TR&#x003b1;1, TR&#x003b2; (all forms) or both genes, comparing these responses with those of hypothyroid animals to distinguish the specific contributions of receptor expression and activation. We report that TRs are not required for liver regeneration; however, hypothyroid mice and TR&#x003b2;&#x02013; or TR&#x003b1;1/TR&#x003b2;&#x02013;deficient mice exhibit a delay in the restoration of liver mass. This delay involves a later initiation of liver proliferation together with a significant but transient apoptotic response at 48 h after PH. Altered regenerative responses and liver apoptosis in the absence of activated TR&#x003b2; are linked to an enhanced nitrosative stress, resulting from a drop in the levels of asymmetric dimethylarginine (ADMA), a potent physiological inhibitor of nitric oxide synthase activity (NOS) <xref ref-type="bibr" rid="pone.0008710-Nijveldt1">&#x0005b;14&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008710-Siroen1">&#x0005b;15&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008710-Wilcken1">&#x0005b;16&#x0005d;</xref>.</p></sec><sec id="s2" sec-type="materials|methods"><title>Materials and Methods</title><sec id="s2a"><title>Ethics Statement</title><p>Animals were treated in accordance with the protocols issued by the &#x02018;Ethics Committee for Animal Experimentation&#x02019; of the Instituto de Investigaciones Biom&#x000e9;dicas (CSIC-UAM), which followed National (normative 1201/2005) and International recommendations (normative 609/86 from EU).</p></sec><sec id="s2b"><title>Chemicals</title><p>Antibodies were from Santa Cruz Biotech. (Santa Cruz, CA), Chemicon (Temecula, CA, USA), and BD Transduction Laboratories (San Jose, CA, USA). Other reagents were from Roche (Mannheim, Germany) or Sigma (St. Louis, MO).</p></sec><sec id="s2c"><title>Animals and PH</title><p>TR&#x003b2; single KO and TR&#x003b1;1/TR&#x003b2; double KO mice &#x02013;referred to as KO group- and the corresponding WT animals in the same genetic background (129/Sv&#x000d7;C57BL/6J; <xref ref-type="bibr" rid="pone.0008710-Gothe1">&#x0005b;17&#x0005d;</xref>) were bred in our animal facility. TR&#x003b1;1/TR&#x003b2; double KO mice were generated from TR&#x003b1;1<sup>&#x02212;/&#x02212;</sup>/TR&#x003b2;<sup>&#x0002b;/&#x02212;</sup> KO mice as previously described <xref ref-type="bibr" rid="pone.0008710-Gothe1">&#x0005b;17&#x0005d;</xref>. Five to eight animals per group (except otherwise stated) aged 2&#x02013;3 months were supplied with food and water <italic>ad libitum</italic> and exposed to a 12 h light-dark cycle. For PH, mice were anesthetized with a 92&#x02236;7 mg/kg mix of ketamine&#x02236;xylacine and subjected to midventral laparotomy with 70&#x00025; liver resection (left lower and upper and right upper lobes), and the weight of the excised liver was determined. Sham surgery entailed midventral laparotomy. Survival was higher than 80&#x00025; and all deaths were due to post-surgery complications during the first 24 h post-PH. Liver regeneration index was calculated as the ratio of the liver remnant to body mass and &#x000d7;100). Hypothyroidism was induced by administration during 4 weeks of methimazole (MMI) (0.05&#x00025;) and KClO<sub>4</sub> (1&#x00025;) in the drinking water <xref ref-type="bibr" rid="pone.0008710-Weiss1">&#x0005b;18&#x0005d;</xref>. When required, L-thyroxine (T4) was administered to MMI-hypothyroid mice at 20 ng/g body weight per day for a week. Plasma was obtained from the aorta and allowed to clot. Serum was stored at &#x02212;80&#x000b0;C. The activity of aspartate aminotransferase (AST) in serum was measured to evaluate liver injury, using a commercial assay kit (Roche).</p></sec><sec id="s2d"><title>Hydrodynamic transfection</title><p>Liver-specific transfection was accomplished by hydrodynamic overload with 100 &#x000b5;g plasmid (void vector pLPCX, pGFP, or a 1&#x02236;10 ration of pGFP&#x02236;pTR&#x003b2;) dissolved in 2 ml isotonic NaCl. The plasmid solution was injected during 8 s into the tail veins of 22&#x02013;24 g adult male mice (hydrodynamic injection) <xref ref-type="bibr" rid="pone.0008710-Zeini1">&#x0005b;19&#x0005d;</xref>. Animals were subjected to PH 24 h after injection and liver sections were used to evaluate the transfection efficiency, using GFP as marker.</p></sec><sec id="s2e"><title>Flow cytometry of isolated liver cells</title><p>Liver sections (3 mm) were processed in a Dako Medimachine equipped with a 50 &#x000b5;m Medicon filter to disaggregate the tissue and yield individual cells. Cells were fixed in 70&#x00025; ethanol and stained with Red Nile and Hoechst 33342 to evaluate ploidy or with Ki67 to identify proliferative cells; cells were analyzed in a BD FACS Canto II cell cytometer.</p></sec><sec id="s2f"><title>Western blot</title><p>Equal amounts of protein (10&#x02013;50 &#x000b5;g) were size-fractionated by 10&#x02013;12&#x00025; SDS-PAGE, transferred to Hybond P membrane (Amersham) and, after blocking with 5&#x00025; nonfat dry milk, incubated with the corresponding Abs. Commercially available antibodies were used to determine the amounts of TR&#x003b1;, TR&#x003b2;, cyclins E and D1, PCNA, CCAAT/enhancer binding proteins (C/EBP)-&#x003b1; and -&#x003b2;, caspases 3 and 9, glutathione S-transferase (GST), NOS-2 and NOS-3, DDAH-1, farnesoid X receptor (FXR) and the apoptosis-related proteins (Bcl-2, Bax, Bid, IAP-1, x-IAP). Blots were normalized to the expression of &#x003b2;-actin and/or PI3K subunit p85. Multiple film exposure times (CCD camera in a Luminiscent Image Analyzer; LAS 3000, TDI, Madrid) were used to ensure linearity of the band intensities.</p></sec><sec id="s2g"><title>Caspase assays</title><p>Tissue or cell extracts were prepared by homogenization in 10 mM HEPES pH 7.9; 1 mM EGTA, 1 mM EDTA, 120 mM NaCl, 1 mM DTT, 0.5 mM PMSF, 2 &#x000b5;g/ml aprotinin, 10 &#x000b5;g/ml leupeptin, 2 &#x000b5;g/ml TLCK, 5 mM NaF, 1 mM NaVO<sub>4</sub>, 10 mM Na<sub>2</sub>MoO<sub>4</sub> and 0.5&#x00025; Nonidet P-40 (buffer A). After centrifugation of the cell lysate the supernatant was stored at &#x02212;80&#x000b0;C (cytosolic extract) and protein content was assayed with Bio-Rad protein reagent. The activities of caspases 3 and 9 in cytosolic extracts were determined with the fluorogenic substrates N-acetyl-DEVD-7-amino-4-trifluoromethylcoumarin and N-acetyl-LEHD-7-amino-4-trifluoromethylcoumarin, respectively (Calbiochem). The linearity of caspase assays was determined over a 30 min reaction period, and was expressed as percentage <italic>vs.</italic> the activity measured in sham operated animals at 0h.</p></sec><sec id="s2h"><title>Immunofluorescence</title><p>For detection and quantification of apoptosis, the TUNEL commercial kit for cell death detection (Roche) was used following the instructions of the manufacturer. TO-PRO-3 (Molecular Probes) was used for DNA staining. Lipid bodies were stained with Nile red. Images were acquired with a Radiance 2100 confocal microscope (Zeiss).</p></sec><sec id="s2i"><title>RNA isolation and qRT-PCR</title><p>One &#x000b5;g of total RNA, extracted with Trizol Reagent (Invitrogen), was reverse transcribed using 50 U of Expand Reverse transcriptase and pd(N)<sub>6</sub> random hexamer as primer (GE Healthcare). cDNAs were amplified by qRT-PCR with the following oligonucleotide primers: TR&#x003b2; (<named-content content-type="gene">5&#x02032;TGGTGCACTGAAGAATGAGC3&#x02032;</named-content> sense, <named-content content-type="gene">5&#x02032;AGTGGTACCCTGTGGCTTTG3&#x02032;</named-content> antisense, 218 bp), FXR (<named-content content-type="gene">5&#x02032;GCACGCTGATCAGACAGCTA3&#x02032;</named-content> sense, <named-content content-type="gene">5&#x02032;CAGGAGGGTCTGTTGGTCTG3&#x02032;</named-content> antisense, 121 bp), mBSEP (<named-content content-type="gene">5&#x02032; TGGATCAACAGCTCCTTCAA3&#x02032;</named-content> sense, <named-content content-type="gene">5&#x02032;ACACCAACTCCTGCGTAGA3&#x02032;</named-content> antisense, 111bp), DDAH-1 (<named-content content-type="gene">5&#x02032;AGCCGCAGGAAGGAGGTT3&#x02032;</named-content> sense, <named-content content-type="gene">5&#x02032;AATAGGACGTCCCCACCATC3&#x02032;</named-content> antisense, 110 bp) and for 18S rRNA (<named-content content-type="gene">5&#x02032;GCAATTATTCCCCATGAACGA3&#x02032;</named-content> sense, <named-content content-type="gene">5&#x02032;CAAAGGGCAGGGACTTAATCAA3&#x02032;</named-content> antisense, 100 bp). Reactions were performed in triplicate. For each primer pair and cDNA, a dilution series of the input was used to generate a standard curve, from which the Ct value and fold enrichment were calculated (&#x02265;1.5 was considered significant).</p></sec><sec id="s2j"><title>Determination of T3, T4 and metabolites</title><p>The levels of T3 and T4 were determined in serum using an ECL-based kit (Diagnostic Products Corp. Los Angeles, CA). The lower limits of detection were 0.25 ng/ml and 3.5 ng/ml for T3 and T4, respectively. Triglycerides (TAG) and cholesterol (Cho) were determined in liver homogenates by enzymatic methods with specific kits from Biosystems (Barcelona). Nitrotyrosine and ADMA were determined using a specific ELISA kit (Chemicon). GSH, GSSG, malondialdehyde (MDA) and 8-oxodeoxyguanosine (8-oxo-dG) were determined as previously described <xref ref-type="bibr" rid="pone.0008710-Mojena1">&#x0005b;20&#x0005d;</xref>. Protein concentrations were determined with Bradford reagent.</p></sec><sec id="s2k"><title>DDAH activity</title><p>DDAH-1 activity was measured from the conversion of L-N-monomethylarginine (L-NMMA) into L-citrulline. Liver samples (50 mg) were homogenized in 200 &#x000b5;l buffer A (see above) and centrifuged at 20,000<bold>g</bold> for 15 min. Supernatants were collected and stored at 4&#x000b0;C. To measure DDAH activity 20 &#x000b5;l of the supernatant was incubated for 60 min at 30&#x000b0;C in 80 &#x000b5;l reaction buffer (20 mM Tris; pH 7.4 and 500 &#x000b5;M L-NMMA). The reaction was stopped with 1 ml ice-cold stop buffer (20 mM HEPES; pH 5.5 and 2 mM EDTA). L-citrulline was separated from L-NMMA with the cation exchange resin Dowex AG50 X8-400. Aliquots of the eluent were used to determine the concentration of L-citrulline by HPLC in an amino acid analyzer. One unit of DDAH-1 activity corresponded to the synthesis of one nanomol of L-citrulline per minute.</p></sec><sec id="s2l"><title>Data analysis</title><p>Data are expressed as means &#x000b1; standard deviation (SD). Statistical significance was estimated with Student's <italic>t</italic> test for unpaired observations. The results were considered significant at <italic>P</italic>&#x0003c;<italic>0.05</italic>. Data were analyzed with the SPSS for Windows statistical package, version 9.0.1.</p></sec></sec><sec id="s3"><title>Results</title><sec id="s3a"><title>TR&#x003b2; expression transiently decreases in regenerating liver after PH</title><p>Expression levels of TR&#x003b1; and TR&#x003b2; were determined in liver extracts from animals that had undergone PH. TR&#x003b1; content did not change in the period after PH; however, TR&#x003b2; decreased significantly 24&#x02013;72 h post-PH, returning to control levels at 96 h (<xref ref-type="fig" rid="pone-0008710-g001">Fig. 1A&#x02013;B</xref>). Western blot confirmed absence of TR&#x003b1;1 and TR&#x003b2; from TR double KO mice. Consistent with the protein expression profile, TR&#x003b2; mRNA expression increased 3-fold by 48&#x02013;72 h (<xref ref-type="fig" rid="pone-0008710-g001">Fig. 1C</xref>). TR&#x003b1;1/TR&#x003b2; double KO mice exhibit a marked hyperthyroidism that has been previously reported <xref ref-type="bibr" rid="pone.0008710-Gothe1">&#x0005b;17&#x0005d;</xref>. The T3 and T4 serum levels were determined after PH and both WT and TR&#x003b1;1/TR&#x003b2; double KO mice exhibited a rapid decrease in thyroid hormone levels after PH that recovered at 72&#x02013;96 h (<xref ref-type="fig" rid="pone-0008710-g001">Fig. 1D</xref>), presumably due to the rapid overexpression of deiodinase type 3 <xref ref-type="bibr" rid="pone.0008710-Kester1">&#x0005b;8&#x0005d;</xref>. Interestingly, the basal thyroid hormone levels of the TR&#x003b1;1/TR&#x003b2; double KO mice where higher than those of WT mice, in agreement with previous work <xref ref-type="bibr" rid="pone.0008710-Gothe1">&#x0005b;17&#x0005d;</xref>. Regarding liver regeneration, TR&#x003b1;1/TR&#x003b2; double KO mice had a slower rate of liver mass recovery after PH than WT, reflected in a delayed increase in the regeneration index (<xref ref-type="fig" rid="pone-0008710-g001">Fig. 1E</xref>). A milder delay was also observed in hypothyroid animals treated with MMI, and the liver regeneration index was restored in these animals by administration of T4. Interestingly, serum AST activity in hepatectomized animals, a marker of liver injury, was about a third of the WT value in the double KO mice, reflecting a decrease in liver injury after PH (<xref ref-type="fig" rid="pone-0008710-g001">Fig. 1F</xref>). This unexpected protection against PH-induced liver injury was systematically observed in TR&#x003b1;1/TR&#x003b2; double KO mice and in MMI treated mice, being lost after administration of T4 in the latter case. Despite the attenuated liver regeneration in TR&#x003b1;1&#x0002b;TR&#x003b2; KO or MMI-treated mice, survival rates after PH in these animals were identical to those in non-treated wild-types (<xref ref-type="fig" rid="pone-0008710-g002">Fig. 2A</xref>). Animal death was usually due to post-surgery complications, and always occurred during the first 24 h after intervention. Determination of cell proliferation, by Ki67-positive cell count in liver sections, revealed delayed progression in the cell cycle in TR&#x003b1;1/TR&#x003b2; KO and MMI-treated mice (<xref ref-type="fig" rid="pone-0008710-g002">Fig. 2B</xref>), while flow cytometry of disaggregated liver cells showed no significant differences in the ploidy distribution among the animal groups (<xref ref-type="fig" rid="pone-0008710-g002">Fig. 2C</xref>). The delayed hepatocyte replication in double-KO and MMI-treated mice was reflected in delayed upregulation in the expression of the cell-cycle markers PCNA and cyclins E and D1 (<xref ref-type="fig" rid="pone-0008710-g002">Fig. 2D</xref>). Moreover, the typical drop in hepatic levels of C/EBP&#x003b1; that normally follows PH, and which is required for progress of hepatocytes through the cell cycle <xref ref-type="bibr" rid="pone.0008710-Callejas1">&#x0005b;21&#x0005d;</xref>, was delayed in double-KO and MMI-treated mice, whereas the increase in C/EBP&#x003b2; levels was much lower in animals lacking functional TRs (<xref ref-type="fig" rid="pone-0008710-g002">Fig. 2D</xref>).</p><fig id="pone-0008710-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0008710.g001</object-id><label>Figure 1</label><caption><title>TR&#x003b2; is transiently downregulated after PH and liver regeneration is delayed in TR&#x003b1;1/TR&#x003b2; double KO mice.</title><p>(A,B) WT and TR&#x003b1;1/TR&#x003b2; KO mice (&#x02018;KO&#x02019;) were submitted to 70&#x00025; PH, and the protein levels of TR&#x003b1;1 (55 kDa) and TR&#x003b2; (47 kDa) were determined by Western blot, and expressed as percentage of the normalized band intensities (using &#x003b2;-actin as control) <italic>vs.</italic> sham operated animals at 0 h. (C) mRNA levels of TR&#x003b1;1 and TR&#x003b2; were determined by quantitative real time RT-PCR. (D) The serum levels of T3 and T4 after PH were measured and expressed as percentage <italic>vs.</italic> sham operated animals at 0 h. The basal values were 7.4&#x000b1;0.5 and 36.5&#x000b1;4.2 &#x000b5;g/dl for T4 in WT and KO, respectively; 78&#x000b1;5 and 2965&#x000b1;307 ng/dl for T3 in WT and KO, respectively. (E) Liver mass recovery after PH was determined in these animals and in WT mice treated with MMI to pharmacologically induce hypothyroidism, and in one group of animals thyroid hormone was restituted by administration of T4. (F) Acute liver injury after PH was evaluated by measuring serum AST levels. Results show means &#x000b1; SD of 6 to 8 animals per condition (B,C,E,F), 4 animals (D) or a representative blot of three (A). #P&#x0003c;0.01 <italic>vs.</italic> the corresponding condition at 0h (B,D); &#x0002a;P&#x0003c;0.05, &#x0002a;&#x0002a;P&#x0003c;0.01 <italic>vs.</italic> WT condition or T4-untreated WT animals (E,F).</p></caption><graphic xlink:href="pone.0008710.g001"/></fig><fig id="pone-0008710-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0008710.g002</object-id><label>Figure 2</label><caption><title>TR&#x003b1;1/TR&#x003b2; deficiency results in delayed hepatocyte proliferation after PH.</title><p>(A) Effect of TR&#x003b1;1/TR&#x003b2; deficiency on survival rates after PH (n&#x0200a;&#x0003d;&#x0200a;19&#x02013;32); animal death occurred in the first 24h post-PH. (B) Percentage of Ki67-positive cells in liver sections. (C) Hepatocyte ploidy distribution determined in preparations of liver disaggregated cells in a Medimachine. (D) Time-course of PCNA, cyclins E and D1, C/EBP&#x003b1; and C/EBP&#x003b2; protein levels determined in liver extracts after PH. Results show means &#x000b1; SD of 6 animals per condition (B,C) or a representative blot of three (D). &#x0002a;P&#x0003c;0.05, &#x0002a;&#x0002a;P&#x0003c;0.01 <italic>vs.</italic> WT condition.</p></caption><graphic xlink:href="pone.0008710.g002"/></fig></sec><sec id="s3b"><title>TR activity prevents transient hepatocyte apoptosis in regenerating liver after PH</title><p>Analysis of apoptosis by TUNEL in regenerating liver identified a transient peak at 48 h after PH in TR&#x003b1;1/TR&#x003b2; KO and MMI-treated mice (<xref ref-type="fig" rid="pone-0008710-g003">Fig. 3A</xref>). This apoptotic response was accompanied by an increased caspase 3 activity in samples of the remnant liver at 48 h (<xref ref-type="fig" rid="pone-0008710-g003">Fig. 3B</xref>). However, other processes relevant to the regenerative response, such as steatosis, evaluated by the accumulation of Nile red positive droplets (<xref ref-type="fig" rid="pone-0008710-g003">Fig. 3C</xref>) and liver cholesterol and triglyceride content (<xref ref-type="fig" rid="pone-0008710-g003">Fig. 3D&#x02013;E</xref>), appeared to be little affected by the lack of functional TRs, although there was a moderate but statistically significant increase (p&#x0003c;0.05) in liver cholesterol and triglycerides in TR&#x003b1;1/TR&#x003b2; KO animals at 48 h.</p><fig id="pone-0008710-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0008710.g003</object-id><label>Figure 3</label><caption><title>TR&#x003b2; inhibits apoptosis in regenerating liver.</title><p>(A) TUNEL staining of cells undergoing apoptosis in regenerating liver (green). Liver sections were obtained at the indicated times after PH. The mean (n&#x0200a;&#x0003d;&#x0200a;5 sections) of TUNEL positive cells per 100 nuclei (blue; TO-PRO-3 staining) is given at 48 h. (B) Caspase 3 activity was determined fluorometrically in liver extracts obtained at the indicated times after PH, and expressed <italic>vs.</italic> the activity of sham samples at 0h. (C) Alternatively, liver sections were stained with eosin/hematoxylin or Nile red to visualize lipid bodies. (D,E) Intrahepatic levels of cholesterol and triglycerides determined in liver extracts obtained at the indicated times after PH. Results show means &#x000b1; SD of 6 animals per condition (B,D,E) or sections from a representative experiment of three (A,C). &#x0002a;P&#x0003c;0.05 <italic>vs.</italic> the WT condition.</p></caption><graphic xlink:href="pone.0008710.g003"/></fig></sec><sec id="s3c"><title>Ectopic expression of TR&#x003b2; in vivo restores liver mass recovery and inhibits apoptosis after PH</title><p>Mice were injected with a bolus of plasmids encoding TR&#x003b2; and GFP to allow hydrodynamic transfection of liver <italic>in vivo</italic><xref ref-type="bibr" rid="pone.0008710-Zeini1">&#x0005b;19&#x0005d;</xref>. An average 40&#x02013;60&#x00025; hepatocytes stained positive for GFP 24 h post transfection (<xref ref-type="fig" rid="pone-0008710-g004">Fig. 4A</xref>). The protein levels of TR&#x003b2; after hydrodynamic transfection are shown in <xref ref-type="fig" rid="pone-0008710-g004">Fig. 4A</xref>. Transfection of TR&#x003b1;1/TR&#x003b2; double KO or TR&#x003b2; KO mice with TR&#x003b2; resulted in a significant increase in liver mass recovery at 48 h after PH (<xref ref-type="fig" rid="pone-0008710-g004">Fig. 4B</xref>), suggesting a specific and non-redundant role for TR&#x003b2; in liver regeneration. Interestingly, overexpression of TR&#x003b2; in WT animals did not modify the regenerative response (WT condition in <xref ref-type="fig" rid="pone-0008710-g004">Fig. 4B</xref>). Ectopic expression of TR&#x003b2; in the KO mice also markedly decreased the expression and activity of caspase 9 and activity of caspase 3 at 48 h PH, as determined in liver extracts (<xref ref-type="fig" rid="pone-0008710-g004">Fig. 4C,D,E</xref>).</p><fig id="pone-0008710-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0008710.g004</object-id><label>Figure 4</label><caption><title>Hydrodynamic transfection of TR&#x003b2; restores liver regeneration index and impairs caspase activation in regenerating liver of TR KO mice.</title><p>Before PH, animals (WT, TR&#x003b2; single KO and TR&#x003b1;1/TR&#x003b2; double KO mice, referred as &#x02018;KO&#x02019;) were transfected hydrodynamically with GFP and TR&#x003b2; expression vectors, or the TR&#x003b2;-void vector pCX. The expression of GFP and the levels of TR&#x003b2; (A), the liver mass regeneration index (B) and the levels of procaspase 3 and caspases 3 and 9 (C) were determined 48 h after PH. (D,E) Activities of caspase 9 and caspase 3 using specific peptide substrates were determined in liver extracts obtained 48 h post-PH. Results show the mean &#x000b1; SD of 5 animals per condition (B,D,E) or a representative section or Western blot out of three (A,C). &#x0002a;P&#x0003c;0.01 <italic>vs.</italic> the WT condition; #P&#x0003c;0.01 <italic>vs.</italic> animals of the same genotype transfected with control TR&#x003b2;-void vector (pCX).</p></caption><graphic xlink:href="pone.0008710.g004"/></fig></sec><sec id="s3d"><title>TR&#x003b2; deficiency decreases ADMA content in regenerating live</title><p>A possible explanation for the increased apoptosis in the regenerating liver of TR KO mice is an enhanced oxidative and/or nitrosative stress. To evaluate oxidative stress, we measured the levels of 8-oxo-deoxyguanosine (8-oxo-dG), malondialdehyde (MDA) and GSH-GSSG, and the activity of glutathione peroxidase (GPx). Neither TR&#x003b2; KO or TR&#x003b1;1/TR&#x003b2; double KO mice showed significant variation in these parameters compared with WT animals, and only a tendency of low statistical significance to higher levels of GSH and lower of 8-oxo-dG was evidenced in the KO model (<xref ref-type="fig" rid="pone-0008710-g005">Fig. 5A</xref>). However, the liver content of nitrotyrosine was elevated in the KO animals (<xref ref-type="fig" rid="pone-0008710-g005">Fig. 5B</xref>), indicating enhanced nitrosative stress. TR&#x003b1;1/TR&#x003b2; gene deficiency did not affect the protein expression level or phosphorylation state of NOS-3, suggesting that the activity of this isoenzyme was not regulated by changes in the phosphorylation of the specific Ser473 residue; however, the characteristic transient spike in NOS-2 expression in regenerating liver <xref ref-type="bibr" rid="pone.0008710-Hortelano1">&#x0005b;22&#x0005d;</xref> was significantly enhanced (<xref ref-type="fig" rid="pone-0008710-g005">Fig. 5C</xref>). Other enzymes induced in regenerating liver, such as glutathione-S-transferase (GST), showed similar profiles in WT and KO mice (<xref ref-type="fig" rid="pone-0008710-g005">Fig. 5C</xref>). The enhanced nitrosative stress in TR&#x003b1;1/TR&#x003b2; double KO mice suggested higher NOS activity. Consistently, serum levels of ADMA &#x02013;a physiological NOS inhibitor <xref ref-type="bibr" rid="pone.0008710-Siroen1">&#x0005b;15&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008710-Wilcken1">&#x0005b;16&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008710-Laleman1">&#x0005b;23&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008710-Vizzutti1">&#x0005b;24&#x0005d;</xref>&#x02013; were specifically decreased in TR&#x003b2; KO and TR&#x003b1;1/TR&#x003b2; double KO mice 24&#x02013;48 h after PH, with the start of recovery evident at 72 h (<xref ref-type="fig" rid="pone-0008710-g006">Fig. 6A</xref>). This ADMA decrease was accompanied by increased expression and activity of DDAH-1, which converts ADMA into citrulline (<xref ref-type="fig" rid="pone-0008710-g006">Fig. 6B</xref>). One candidate regulator of DDAH-I expression in liver is the nuclear receptor FXR <xref ref-type="bibr" rid="pone.0008710-Hu1">&#x0005b;25&#x0005d;</xref>, and the FXR content of liver nuclear extracts was much higher in the TR&#x003b1;1/TR&#x003b2; double KO than in the WT animals (<xref ref-type="fig" rid="pone-0008710-g006">Fig. 6C</xref>). Likewise, mRNA expression of FXR and the bile salt export pump (mBSEP), a target of FXR activity <xref ref-type="bibr" rid="pone.0008710-Hoeke1">&#x0005b;26&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008710-Pope1">&#x0005b;27&#x0005d;</xref>, were always higher in the TR&#x003b1;1/TR&#x003b2; double KO mice than in the WT group, suggesting a higher activity of FXR in these animals after PH (<xref ref-type="fig" rid="pone-0008710-g006">Fig. 6D</xref>). Moreover, whereas FXR mRNA and protein expression showed a decrease at 24 h PH in WT animals, an increase was observed in the TR&#x003b1;1/TR&#x003b2; double KO group. These differential changes in FXR expression might explain the comparatively high expression of DDAH-1 in the regenerating livers of TR&#x003b1;1/TR&#x003b2; double KO mice (<xref ref-type="fig" rid="pone-0008710-g006">Fig. 6B</xref>).</p><fig id="pone-0008710-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0008710.g005</object-id><label>Figure 5</label><caption><title>Metabolic and enzymatic markers of oxidative and nitrosative stress in regenerating liver after PH.</title><p>(A) Content of 8-oxo-deoxyguanosine (8-oxo-dG), malondialdehyde (MDA), GSH and GSSG and the activity of glutathioneperoxidase (GPx) were determined in samples of liver obtained at the indicated times after PH. (B) Nitrosative stress in the remnant liver tissue was determined by ELISA of nitro-tyrosine. (C) Western blots of the protein levels of nitric oxide synthase 2 and 3 (NOS-2, -3) and the phosphorylation state of NOS-3 (at S473), and glutathione-S-transferase (GST). The levels of &#x003b2;-actin were used as control of lane charge (C). Results show means &#x000b1; SD of 5 animals (A,B) or a representative experiment of 3 (C). &#x0002a;P&#x0003c;0.05, &#x0002a;&#x0002a;P&#x0003c;0.001 <italic>vs.</italic> the WT condition (B).</p></caption><graphic xlink:href="pone.0008710.g005"/></fig><fig id="pone-0008710-g006" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0008710.g006</object-id><label>Figure 6</label><caption><title>ADMA levels decrease after PH of MMI-treated WT mice or TR&#x003b2; KO and TR&#x003b1;&#x0002b;TR&#x003b2; double KO mice.</title><p>(A) ADMA was determined in liver extracts at the indicated times after PH. (B) Enzymatic activity and protein and mRNA levels of DDAH I measured in liver extracts at the indicated times. (C) Total protein levels of FXR (59 kDa) were determined in liver extracts using mitochondrial porin (30 kDa) as control. (D) Hepatic levels of FXR and mBSEP mRNA after PH, determined by real-time q-PCR. Results show means &#x000b1; SD of 4 animals (A&#x02013;D) or a representative experiment of 3 (C). &#x0002a;P&#x0003c;0.05, &#x0002a;&#x0002a;P&#x0003c;0.001 <italic>vs.</italic> time-controlled WT. #P&#x0003c;0.01 <italic>vs.</italic> the condition at time 0.</p></caption><graphic xlink:href="pone.0008710.g006"/></fig></sec><sec id="s3e"><title>Inhibition of NOS-2 significantly reduces liver apoptosis in regenerating liver after PH in TR KO mice</title><p>To confirm a contribution by enhanced nitrosative stress to the transient apoptosis detected in regenerating liver in the absence of TR&#x003b2;, PH animals were administered with the NOS-2 inhibitor 1400W, and apoptosis, caspase 3 activity, nitrotyrosine concentration and ADMA levels were determined at 48 h. Treatment with 1400W shifted the apoptotic response, caspase 3 activity and nitrotyrosine levels of PH TR&#x003b1;1/TR&#x003b2; double KO mice down to the range seen in WT counterparts (<xref ref-type="fig" rid="pone-0008710-g007">Fig. 7A</xref>), in spite of the fact that ADMA levels remained notably below those of WT animals (<xref ref-type="fig" rid="pone-0008710-g007">Fig. 7B</xref>). This result suggests that inhibition of NOS-2 is sufficient to prevent apoptosis at 48 h in the remnant liver. Analysis of pro-apoptotic genes at this time showed that expression of Bcl-2, unprocessed Bid and IAP-1 decrease in the TR&#x003b1;1/TR&#x003b2; double KO mice, while Bax expression was significantly increased; treatment with 1400W attenuated or even suppressed these changes. Moreover, 1400W treatment rescued the increased expression of PCNA and cyclin E at 48 h after PH seen in wild-types. Together, these results support a role for enhanced NOS activity in the apoptosis detected in the regenerating liver of TR&#x003b2; or TR&#x003b1;1/TR&#x003b2; double KO mice at 48 h post-PH.</p><fig id="pone-0008710-g007" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0008710.g007</object-id><label>Figure 7</label><caption><title>Inhibition of NOS-2 impairs apoptosis in the remnant liver of TR&#x003b1;1/TR&#x003b2; double KO mice.</title><p>Animals were submitted to PH as described in <xref ref-type="fig" rid="pone-0008710-g001">Fig. 1</xref> and 1400W (20 mg/kg) was administered intraperitoneally 8 h and 32 h after PH, and analyses were done at 48 h. (A) Apoptosis was determined by TUNEL staining of liver sections, caspase 3 activity was measured, and hepatic levels of nitrotyrosine were determined by ELISA. (B) ADMA was measured in liver at 48 h post-PH. (C) Western blots showing the levels of Bcl-2 (26 kDa), Bax (21 kDa), intact Bid (26 kDa), IAP-1 (72 kDa), x-IAP (57 kDa), PCNA and cyclin E in liver extracts obtained at 48 h post-PH. Results show means &#x000b1; SD of 3 animals (A,B) or a representative experiment out of 3 (C). &#x0002a;P&#x0003c;0.05, &#x0002a;&#x0002a;P&#x0003c;0.001 <italic>vs.</italic> the condition in the absence of 1400W.</p></caption><graphic xlink:href="pone.0008710.g007"/></fig></sec></sec><sec id="s4"><title>Discussion</title><p>Previous reports described delayed post-PH liver regeneration in hypothyroid animals <xref ref-type="bibr" rid="pone.0008710-Alisi1">&#x0005b;4&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008710-Dong1">&#x0005b;28&#x0005d;</xref>. Our results confirm these data and show the same effect in animals lacking TRs, despite the hyperthyroidism exhibited by these animals. This delay in the commitment of hepatocytes to proliferation might be related to the proposed role of T3 in cell-cycle regulation, including activation of cyclin D1 and enhancement of cell viability <xref ref-type="bibr" rid="pone.0008710-Pibiri1">&#x0005b;6&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008710-Kariv1">&#x0005b;7&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008710-LaoagFernandez1">&#x0005b;29&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008710-Sukocheva1">&#x0005b;30&#x0005d;</xref>. Interestingly, overexpression of TR&#x003b2; by hydrodynamic overload did not modify the regenerative PH response in WT animals, but did significantly restore the regeneration in TR&#x003b2; KO mice. However, in hyperthyroid animals liver apoptosis occurs through a mechanism that appears to involve TNF-&#x003b1; signaling in the absence of NF-&#x003ba;B activation <xref ref-type="bibr" rid="pone.0008710-Kumar1">&#x0005b;31&#x0005d;</xref>, a condition clearly absent in animals overexpressing the receptor TR&#x003b2; in liver.</p><p>The first important finding of this study is that the absence of both TR&#x003b1; and TR&#x003b2;, a condition that suppresses binding of T3 to nuclear liver extracts <xref ref-type="bibr" rid="pone.0008710-Gothe1">&#x0005b;17&#x0005d;</xref>, does not affect post-PH survival rates, indicating that neither of these genes is required for regeneration, despite the delay observed in the restoration of liver mass. Previous reports described anti-apoptotic effects of that TR activation in hepatocytes <xref ref-type="bibr" rid="pone.0008710-Sukocheva1">&#x0005b;30&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008710-Kucharova1">&#x0005b;32&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008710-Saelim1">&#x0005b;33&#x0005d;</xref> and in other cell types; for example, pancreatic beta cells and oligodendrocytes <xref ref-type="bibr" rid="pone.0008710-Jones1">&#x0005b;34&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008710-VergaFalzacappa1">&#x0005b;35&#x0005d;</xref>. A likely mediator of pro-apoptotic activity in hypothyroidism or in the absence of TRs is increased oxidative stress due to the lack of T3 signaling <xref ref-type="bibr" rid="pone.0008710-Grant1">&#x0005b;36&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008710-Messarah1">&#x0005b;37&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008710-Venditti1">&#x0005b;38&#x0005d;</xref>. However, this possibility is discounted by the lack of significant differences in oxidative stress parameters between the regenerating livers of WT and TRs KO mice (apparently, the levels of GSH and 8-oxo-dG are even higher in the KO mice). In contrast, lack of TR activity increased nitrosative stress, as evidenced by higher amounts of nitrated proteins and nitrotyrosine in the TR KO mice. NOS-3 activity was unchanged post-PH, while NOS-2 was transiently overexpressed in TR KO mice with respect to WT animals. We therefore focused attention on regulatory molecules that affect these enzymes' activities <xref ref-type="bibr" rid="pone.0008710-Zeini1">&#x0005b;19&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008710-Mojena1">&#x0005b;20&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008710-Hortelano1">&#x0005b;22&#x0005d;</xref>. Basic and clinical studies indicate that regulation of NOS activity is pathophysiologically relevant, whether achieved by limiting arginine transport or direct inhibition by dimethylarginine derivatives <xref ref-type="bibr" rid="pone.0008710-Wilcken1">&#x0005b;16&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008710-Laleman1">&#x0005b;23&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008710-Vizzutti1">&#x0005b;24&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008710-Palm1">&#x0005b;39&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008710-Wang1">&#x0005b;40&#x0005d;</xref>. Consistently, elevated ADMA levels correlate with post-PH liver dysfunction <xref ref-type="bibr" rid="pone.0008710-Siroen1">&#x0005b;15&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008710-Nijveldt2">&#x0005b;41&#x0005d;</xref>. In this regard, ADMA levels remained stable in the WT group, but decreased notably in the course of liver regeneration in hypothyroid and TRs KO animals, offering a possible explanation for the enhanced NOS activity <xref ref-type="bibr" rid="pone.0008710-Laleman1">&#x0005b;23&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008710-Frey1">&#x0005b;42&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008710-Leiper1">&#x0005b;43&#x0005d;</xref>. ADMA is cleared by the action of the liver enzyme DDAH-1 <xref ref-type="bibr" rid="pone.0008710-Hu1">&#x0005b;25&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008710-Pope1">&#x0005b;27&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008710-Palm1">&#x0005b;39&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008710-Chobanyan1">&#x0005b;44&#x0005d;</xref>. The higher expression and activity of DDAH-1 in TR KO liver suggests that this enzyme is regulated during liver regeneration in the TR-deficient mice. DDAH-1 transcription in liver has been proposed to be regulated by FXR <xref ref-type="bibr" rid="pone.0008710-Hu1">&#x0005b;25&#x0005d;</xref>; our finding that FXR expression is modified during liver regeneration and is significantly higher in TR KO mice supports a role for this nuclear receptor. This is further supported by the similar expression profile observed for mBSEP, a highly FXR-responsive gene <xref ref-type="bibr" rid="pone.0008710-Huang1">&#x0005b;45&#x0005d;</xref>. Although pharmacologic studies modulating FXR activity have not been performed, it is possible that partial inhibition of FXR in the PH liver of WT mice might prevent increases in DDAH-1 expression, thereby maintaining ADMA levels stable.</p><p>The scheme shown in <xref ref-type="fig" rid="pone-0008710-g008">Fig. 8</xref> presents a picture of the possible mechanisms involved in the transient liver apoptosis at 48h after PH. In the livers of animals lacking TR activity, DDAH-1, probably regulated by FXR activity, is overexpressed. Consequently, ADMA levels drop, favoring a higher NOS-2/NOS-3 activity in the course of liver regeneration, particularly NOS-2, which is transiently expressed at this time. Also, it is noteworthy the observation that transient NOS-2 levels in the TR KO mice are higher than in the WT counterparts. This associated overproduction of NO enhances nitrosative stress and promotes apoptosis.</p><fig id="pone-0008710-g008" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0008710.g008</object-id><label>Figure 8</label><caption><title>Possible mechanisms leading to apoptosis in the regenerating liver of TR&#x003b1;1/TR&#x003b2; double KO mice after PH.</title><p>Loss of signaling via TR&#x003b2;, through TR gene deletion or MMI treatment, promotes a transient increase in FXR levels and activity favoring an increase in DDAH-1 activity that reduces ADMA levels &#x02013;a NOS inhibitor- and promotes the synthesis of higher levels of NO. This enhancement in the activity of hepatic NOS induces nitrosative stress and promotes apoptosis. Inhibition of NOS-2 activity with 1400W, a selective inhibitor, abrogates nitrosative stress in liver and partially prevents apoptosis at 48 h after PH in TR&#x003b2;-targeted mice (<xref ref-type="fig" rid="pone-0008710-g007">Fig. 7</xref>).</p></caption><graphic xlink:href="pone.0008710.g008"/></fig><p>The question remains as to what causes the delay to the commitment of cells to the first round of proliferation. Among other possibilities, the absence of TR activity might contribute to an altered pattern of cyclin expression, as previously mentioned <xref ref-type="bibr" rid="pone.0008710-Pibiri1">&#x0005b;6&#x0005d;</xref>. Such an association is not unprecedented: in animals lacking caveolin 1, hepatocytes are committed more rapidly to the expression of cyclin E and A, and these cyclins are present in the nucleus 12 h after PH, accelerating the rate of regeneration; in WT counterparts these events do not occur before 24 h <xref ref-type="bibr" rid="pone.0008710-Mayoral1">&#x0005b;46&#x0005d;</xref>. An alternative mechanism relates to the temporal coincidence of NOS-2 expression, the drop in ADMA levels and the initiation of S-phase; this raises the possibility that over-activation of NOS-2 kills proliferating hepatocytes by apoptosis. This view is supported by administration of NO donors or induction of NO production from a PEPCK-regulated NOS-2 transgene, both of which delay expression of cyclin E, D1 and PCNA, postponing the onset of liver regeneration <xref ref-type="bibr" rid="pone.0008710-Zeini1">&#x0005b;19&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0008710-Mojena1">&#x0005b;20&#x0005d;</xref>. Interestingly, the apoptosis occurring at 48h (&#x0223c;30&#x00025; of the cells) is unable to influence the PH survival rate, highlighting the ability of liver to regenerate after acute injury.</p><p>The results presented here provide insight into the protective effects of thyroid hormones in the regenerating liver, mediated by preventing nitrosative stress and favoring the initiation of the proliferative response of the remnant liver. A contribution of thyroid hormones to the regulation of NOS activity during liver regeneration was unexpected, and this finding underlines the value of studying liver regeneration in whole animals. This allows of identification of the role of metabolites such as dimethylarginine derivatives in the regulation of NOS-3, involved in the vascular function, and NOS-2, transiently expressed in the regenerating hepatocyte. The role of thyroid status in other liver pathologies deserves further study.</p></sec></body><back><ack><p>We thank Dr. Simon Bartlett for discussion, advice and critical reading of the manuscript, and Dr. Bj&#x000f6;rn Vennstr&#x000f6;m (Karolinska Institutet, Stockholm, Sweden) for providing mice for the establishment of the knock-out colonies.</p></ack><ref-list><title>References</title><ref id="pone.0008710-Michalopoulos1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michalopoulos</surname><given-names>GK</given-names></name><name><surname>DeFrances</surname><given-names>MC</given-names></name></person-group><year>1997</year><article-title>Liver regeneration.</article-title><source>Science</source><volume>276</volume><fpage>60</fpage><lpage>66</lpage><pub-id pub-id-type="pmid">9082986</pub-id></mixed-citation></ref><ref id="pone.0008710-Fausto1"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fausto</surname><given-names>N</given-names></name></person-group><year>2000</year><article-title>Liver regeneration.</article-title><source>JHepatol</source><volume>32</volume><fpage>19</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">10728791</pub-id></mixed-citation></ref><ref id="pone.0008710-Fausto2"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fausto</surname><given-names>N</given-names></name><name><surname>Campbell</surname><given-names>JS</given-names></name><name><surname>Riehle</surname><given-names>KJ</given-names></name></person-group><year>2006</year><article-title>Liver regeneration.</article-title><source>Hepatology</source><volume>43</volume><fpage>S45</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">16447274</pub-id></mixed-citation></ref><ref id="pone.0008710-Alisi1"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alisi</surname><given-names>A</given-names></name><name><surname>Demori</surname><given-names>I</given-names></name><name><surname>Spagnuolo</surname><given-names>S</given-names></name><name><surname>Pierantozzi</surname><given-names>E</given-names></name><name><surname>Fugassa</surname><given-names>E</given-names></name><etal/></person-group><year>2005</year><article-title>Thyroid status affects rat liver regeneration after partial hepatectomy by regulating cell cycle and apoptosis.</article-title><source>Cell Physiol Biochem</source><volume>15</volume><fpage>69</fpage><lpage>76</lpage><pub-id pub-id-type="pmid">15665517</pub-id></mixed-citation></ref><ref id="pone.0008710-FloresMorales1"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flores-Morales</surname><given-names>A</given-names></name><name><surname>Gullberg</surname><given-names>H</given-names></name><name><surname>Fernandez</surname><given-names>L</given-names></name><name><surname>Stahlberg</surname><given-names>N</given-names></name><name><surname>Lee</surname><given-names>NH</given-names></name><etal/></person-group><year>2002</year><article-title>Patterns of liver gene expression governed by TRbeta.</article-title><source>Mol Endocrinol</source><volume>16</volume><fpage>1257</fpage><lpage>1268</lpage><pub-id pub-id-type="pmid">12040013</pub-id></mixed-citation></ref><ref id="pone.0008710-Pibiri1"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pibiri</surname><given-names>M</given-names></name><name><surname>Ledda-Columbano</surname><given-names>GM</given-names></name><name><surname>Cossu</surname><given-names>C</given-names></name><name><surname>Simbula</surname><given-names>G</given-names></name><name><surname>Menegazzi</surname><given-names>M</given-names></name><etal/></person-group><year>2001</year><article-title>Cyclin D1 is an early target in hepatocyte proliferation induced by thyroid hormone (T3).</article-title><source>FASEB J</source><volume>15</volume><fpage>1006</fpage><lpage>1013</lpage><pub-id pub-id-type="pmid">11292661</pub-id></mixed-citation></ref><ref id="pone.0008710-Kariv1"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kariv</surname><given-names>R</given-names></name><name><surname>Enden</surname><given-names>A</given-names></name><name><surname>Zvibel</surname><given-names>I</given-names></name><name><surname>Rosner</surname><given-names>G</given-names></name><name><surname>Brill</surname><given-names>S</given-names></name><etal/></person-group><year>2003</year><article-title>Triiodothyronine and interleukin-6 (IL-6) induce expression of HGF in an immortalized rat hepatic stellate cell line.</article-title><source>Liver Int</source><volume>23</volume><fpage>187</fpage><lpage>193</lpage><pub-id pub-id-type="pmid">12955882</pub-id></mixed-citation></ref><ref id="pone.0008710-Kester1"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kester</surname><given-names>MH</given-names></name><name><surname>Toussaint</surname><given-names>MJ</given-names></name><name><surname>Punt</surname><given-names>CA</given-names></name><name><surname>Matondo</surname><given-names>R</given-names></name><name><surname>Aarnio</surname><given-names>AM</given-names></name><etal/></person-group><year>2009</year><article-title>Large induction of type III deiodinase expression after partial hepatectomy in the regenerating mouse and rat liver.</article-title><source>Endocrinology</source><volume>150</volume><fpage>540</fpage><lpage>545</lpage><pub-id pub-id-type="pmid">18787028</pub-id></mixed-citation></ref><ref id="pone.0008710-Tien1"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tien</surname><given-names>ES</given-names></name><name><surname>Matsui</surname><given-names>K</given-names></name><name><surname>Moore</surname><given-names>R</given-names></name><name><surname>Negishi</surname><given-names>M</given-names></name></person-group><year>2007</year><article-title>The nuclear receptor constitutively active/androstane receptor regulates type 1 deiodinase and thyroid hormone activity in the regenerating mouse liver.</article-title><source>J Pharmacol Exp Ther</source><volume>320</volume><fpage>307</fpage><lpage>313</lpage><pub-id pub-id-type="pmid">17050775</pub-id></mixed-citation></ref><ref id="pone.0008710-Rodd1"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodd</surname><given-names>C</given-names></name><name><surname>Schwartz</surname><given-names>HL</given-names></name><name><surname>Strait</surname><given-names>KA</given-names></name><name><surname>Oppenheimer</surname><given-names>JH</given-names></name></person-group><year>1992</year><article-title>Ontogeny of hepatic nuclear triiodothyronine receptor isoforms in the rat.</article-title><source>Endocrinology</source><volume>131</volume><fpage>2559</fpage><lpage>2564</lpage><pub-id pub-id-type="pmid">1446599</pub-id></mixed-citation></ref><ref id="pone.0008710-Schwartz1"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwartz</surname><given-names>HL</given-names></name><name><surname>Strait</surname><given-names>KA</given-names></name><name><surname>Ling</surname><given-names>NC</given-names></name><name><surname>Oppenheimer</surname><given-names>JH</given-names></name></person-group><year>1992</year><article-title>Quantitation of rat tissue thyroid hormone binding receptor isoforms by immunoprecipitation of nuclear triiodothyronine binding capacity.</article-title><source>J Biol Chem</source><volume>267</volume><fpage>11794</fpage><lpage>11799</lpage><pub-id pub-id-type="pmid">1601852</pub-id></mixed-citation></ref><ref id="pone.0008710-Yen1"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yen</surname><given-names>PMFX</given-names></name><name><surname>Flamant</surname><given-names>F</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Walker</surname><given-names>RL</given-names></name><name><surname>Weiss</surname><given-names>RE</given-names></name><name><surname>Chassande</surname><given-names>O</given-names></name><name><surname>Samarut</surname><given-names>J</given-names></name><name><surname>Refetoff</surname><given-names>S</given-names></name><name><surname>Meltzer</surname><given-names>PS</given-names></name></person-group><year>2003</year><article-title>Effects of ligand and thyroid hormone receptor isoforms on hepatic gene expression profiles of thyroid hormone receptor knockout mice.</article-title><source>EMBO Rep</source><volume>4</volume><fpage>581</fpage><lpage>587</lpage><pub-id pub-id-type="pmid">12776178</pub-id></mixed-citation></ref><ref id="pone.0008710-Sun1"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Deng</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Yan</surname><given-names>Y</given-names></name><name><surname>Wei</surname><given-names>H</given-names></name><etal/></person-group><year>2007</year><article-title>Liver proteome analysis of adaptive response in rat immediately after partial hepatectomy.</article-title><source>Proteomics</source><volume>7</volume><fpage>4398</fpage><lpage>4407</lpage><pub-id pub-id-type="pmid">17979177</pub-id></mixed-citation></ref><ref id="pone.0008710-Nijveldt1"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nijveldt</surname><given-names>RJ</given-names></name><name><surname>Siroen</surname><given-names>MP</given-names></name><name><surname>Teerlink</surname><given-names>T</given-names></name><name><surname>van Lambalgen</surname><given-names>AA</given-names></name><name><surname>Rauwerda</surname><given-names>JA</given-names></name><etal/></person-group><year>2004</year><article-title>Gut and liver handling of asymmetric and symmetric dimethylarginine in the rat under basal conditions and during endotoxemia.</article-title><source>Liver Int</source><volume>24</volume><fpage>510</fpage><lpage>518</lpage><pub-id pub-id-type="pmid">15482350</pub-id></mixed-citation></ref><ref id="pone.0008710-Siroen1"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siroen</surname><given-names>MP</given-names></name><name><surname>van der Sijp</surname><given-names>JR</given-names></name><name><surname>Teerlink</surname><given-names>T</given-names></name><name><surname>van Schaik</surname><given-names>C</given-names></name><name><surname>Nijveldt</surname><given-names>RJ</given-names></name><etal/></person-group><year>2005</year><article-title>The human liver clears both asymmetric and symmetric dimethylarginine.</article-title><source>Hepatology</source><volume>41</volume><fpage>559</fpage><lpage>565</lpage><pub-id pub-id-type="pmid">15726655</pub-id></mixed-citation></ref><ref id="pone.0008710-Wilcken1"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilcken</surname><given-names>DE</given-names></name><name><surname>Sim</surname><given-names>AS</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>XL</given-names></name></person-group><year>2007</year><article-title>Asymmetric dimethylarginine (ADMA) in vascular, renal and hepatic disease and the regulatory role of L-arginine on its metabolism.</article-title><source>Mol Genet Metab</source><volume>91</volume><fpage>309</fpage><lpage>317</lpage><comment>discussion 308</comment><pub-id pub-id-type="pmid">17560156</pub-id></mixed-citation></ref><ref id="pone.0008710-Gothe1"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gothe</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Ng</surname><given-names>L</given-names></name><name><surname>Kindblom</surname><given-names>JM</given-names></name><name><surname>Barros</surname><given-names>AC</given-names></name><etal/></person-group><year>1999</year><article-title>Mice devoid of all known thyroid hormone receptors are viable but exhibit disorders of the pituitary-thyroid axis, growth, and bone maturation.</article-title><source>Genes Dev</source><volume>13</volume><fpage>1329</fpage><lpage>1341</lpage><pub-id pub-id-type="pmid">10346821</pub-id></mixed-citation></ref><ref id="pone.0008710-Weiss1"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weiss</surname><given-names>RE</given-names></name><name><surname>Murata</surname><given-names>Y</given-names></name><name><surname>Cua</surname><given-names>K</given-names></name><name><surname>Hayashi</surname><given-names>Y</given-names></name><name><surname>Seo</surname><given-names>H</given-names></name><etal/></person-group><year>1998</year><article-title>Thyroid hormone action on liver, heart, and energy expenditure in thyroid hormone receptor beta-deficient mice.</article-title><source>Endocrinology</source><volume>139</volume><fpage>4945</fpage><lpage>4952</lpage><pub-id pub-id-type="pmid">9832432</pub-id></mixed-citation></ref><ref id="pone.0008710-Zeini1"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeini</surname><given-names>M</given-names></name><name><surname>Hortelano</surname><given-names>S</given-names></name><name><surname>Traves</surname><given-names>PG</given-names></name><name><surname>Gomez-Valades</surname><given-names>AG</given-names></name><name><surname>Pujol</surname><given-names>A</given-names></name><etal/></person-group><year>2005</year><article-title>Assessment of a dual regulatory role for NO in liver regeneration after partial hepatectomy: protection against apoptosis and retardation of hepatocyte proliferation.</article-title><source>FASEB J</source><volume>19</volume><fpage>995</fpage><lpage>997</lpage><pub-id pub-id-type="pmid">15788446</pub-id></mixed-citation></ref><ref id="pone.0008710-Mojena1"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mojena</surname><given-names>M</given-names></name><name><surname>Hortelano</surname><given-names>S</given-names></name><name><surname>Castrillo</surname><given-names>A</given-names></name><name><surname>Diaz-Guerra</surname><given-names>MJ</given-names></name><name><surname>Garcia-Barchino</surname><given-names>MJ</given-names></name><etal/></person-group><year>2001</year><article-title>Protection by nitric oxide against liver inflammatory injury in animals carrying a nitric oxide synthase-2 transgene.</article-title><source>FASEB J</source><volume>15</volume><fpage>583</fpage><lpage>585</lpage><pub-id pub-id-type="pmid">11259374</pub-id></mixed-citation></ref><ref id="pone.0008710-Callejas1"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Callejas</surname><given-names>NA</given-names></name><name><surname>Bosca</surname><given-names>L</given-names></name><name><surname>Williams</surname><given-names>CS</given-names></name><name><surname>Du</surname><given-names>BR</given-names></name><name><surname>Martin-Sanz</surname><given-names>P</given-names></name></person-group><year>2000</year><article-title>Regulation of cyclooxygenase 2 expression in hepatocytes by CCAAT/enhancer-binding proteins.</article-title><source>Gastroenterology</source><volume>119</volume><fpage>493</fpage><lpage>501</lpage><pub-id pub-id-type="pmid">10930384</pub-id></mixed-citation></ref><ref id="pone.0008710-Hortelano1"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hortelano</surname><given-names>S</given-names></name><name><surname>Dewez</surname><given-names>B</given-names></name><name><surname>Genaro</surname><given-names>AM</given-names></name><name><surname>Diaz-Guerra</surname><given-names>MJ</given-names></name><name><surname>Bosca</surname><given-names>L</given-names></name></person-group><year>1995</year><article-title>Nitric oxide is released in regenerating liver after partial hepatectomy.</article-title><source>Hepatology</source><volume>21</volume><fpage>776</fpage><lpage>786</lpage><pub-id pub-id-type="pmid">7533126</pub-id></mixed-citation></ref><ref id="pone.0008710-Laleman1"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laleman</surname><given-names>W</given-names></name><name><surname>Omasta</surname><given-names>A</given-names></name><name><surname>Van de Casteele</surname><given-names>M</given-names></name><name><surname>Zeegers</surname><given-names>M</given-names></name><name><surname>Vander Elst</surname><given-names>I</given-names></name><etal/></person-group><year>2005</year><article-title>A role for asymmetric dimethylarginine in the pathophysiology of portal hypertension in rats with biliary cirrhosis.</article-title><source>Hepatology</source><volume>42</volume><fpage>1382</fpage><lpage>1390</lpage><pub-id pub-id-type="pmid">16317694</pub-id></mixed-citation></ref><ref id="pone.0008710-Vizzutti1"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vizzutti</surname><given-names>F</given-names></name><name><surname>Romanelli</surname><given-names>RG</given-names></name><name><surname>Arena</surname><given-names>U</given-names></name><name><surname>Rega</surname><given-names>L</given-names></name><name><surname>Brogi</surname><given-names>M</given-names></name><etal/></person-group><year>2007</year><article-title>ADMA correlates with portal pressure in patients with compensated cirrhosis.</article-title><source>Eur J Clin Invest</source><volume>37</volume><fpage>509</fpage><lpage>515</lpage><pub-id pub-id-type="pmid">17537159</pub-id></mixed-citation></ref><ref id="pone.0008710-Hu1"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>T</given-names></name><name><surname>Chouinard</surname><given-names>M</given-names></name><name><surname>Cox</surname><given-names>AL</given-names></name><name><surname>Sipes</surname><given-names>P</given-names></name><name><surname>Marcelo</surname><given-names>M</given-names></name><etal/></person-group><year>2006</year><article-title>Farnesoid X receptor agonist reduces serum asymmetric dimethylarginine levels through hepatic dimethylarginine dimethylaminohydrolase-1 gene regulation.</article-title><source>J Biol Chem</source><volume>281</volume><fpage>39831</fpage><lpage>39838</lpage><pub-id pub-id-type="pmid">17065154</pub-id></mixed-citation></ref><ref id="pone.0008710-Hoeke1"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoeke</surname><given-names>MO</given-names></name><name><surname>Plass</surname><given-names>JR</given-names></name><name><surname>Heegsma</surname><given-names>J</given-names></name><name><surname>Geuken</surname><given-names>M</given-names></name><name><surname>van Rijsbergen</surname><given-names>D</given-names></name><etal/></person-group><year>2009</year><article-title>Low retinol levels differentially modulate bile salt-induced expression of human and mouse hepatic bile salt transporters.</article-title><source>Hepatology</source><volume>49</volume><fpage>151</fpage><lpage>159</lpage><pub-id pub-id-type="pmid">19111018</pub-id></mixed-citation></ref><ref id="pone.0008710-Pope1"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pope</surname><given-names>AJ</given-names></name><name><surname>Druhan</surname><given-names>L</given-names></name><name><surname>Guzman</surname><given-names>JE</given-names></name><name><surname>Forbes</surname><given-names>SP</given-names></name><name><surname>Murugesan</surname><given-names>V</given-names></name><etal/></person-group><year>2007</year><article-title>Role of DDAH-1 in lipid peroxidation product-mediated inhibition of endothelial NO generation.</article-title><source>Am J Physiol Cell Physiol</source><volume>293</volume><fpage>C1679</fpage><lpage>1686</lpage><pub-id pub-id-type="pmid">17881609</pub-id></mixed-citation></ref><ref id="pone.0008710-Dong1"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>H</given-names></name><name><surname>Yauk</surname><given-names>CL</given-names></name><name><surname>Williams</surname><given-names>A</given-names></name><name><surname>Lee</surname><given-names>A</given-names></name><name><surname>Douglas</surname><given-names>GR</given-names></name><etal/></person-group><year>2007</year><article-title>Hepatic gene expression changes in hypothyroid juvenile mice: characterization of a novel negative thyroid-responsive element.</article-title><source>Endocrinology</source><volume>148</volume><fpage>3932</fpage><lpage>3940</lpage><pub-id pub-id-type="pmid">17463053</pub-id></mixed-citation></ref><ref id="pone.0008710-LaoagFernandez1"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laoag-Fernandez</surname><given-names>JB</given-names></name><name><surname>Matsuo</surname><given-names>H</given-names></name><name><surname>Murakoshi</surname><given-names>H</given-names></name><name><surname>Hamada</surname><given-names>AL</given-names></name><name><surname>Tsang</surname><given-names>BK</given-names></name><etal/></person-group><year>2004</year><article-title>3,5,3&#x02032;-Triiodothyronine down-regulates Fas and Fas ligand expression and suppresses caspase-3 and poly (adenosine 5&#x02032;-diphosphate-ribose) polymerase cleavage and apoptosis in early placental extravillous trophoblasts in vitro.</article-title><source>J Clin Endocrinol Metab</source><volume>89</volume><fpage>4069</fpage><lpage>4077</lpage><pub-id pub-id-type="pmid">15292350</pub-id></mixed-citation></ref><ref id="pone.0008710-Sukocheva1"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sukocheva</surname><given-names>OA</given-names></name><name><surname>Carpenter</surname><given-names>DO</given-names></name></person-group><year>2006</year><article-title>Anti-apoptotic effects of 3,5,3&#x02032;-tri-iodothyronine in mouse hepatocytes.</article-title><source>J Endocrinol</source><volume>191</volume><fpage>447</fpage><lpage>458</lpage><pub-id pub-id-type="pmid">17088414</pub-id></mixed-citation></ref><ref id="pone.0008710-Kumar1"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Sinha</surname><given-names>RA</given-names></name><name><surname>Tiwari</surname><given-names>M</given-names></name><name><surname>Singh</surname><given-names>R</given-names></name><name><surname>Koji</surname><given-names>T</given-names></name><etal/></person-group><year>2007</year><article-title>Hyperthyroidism induces apoptosis in rat liver through activation of death receptor-mediated pathways.</article-title><source>J Hepatol</source><volume>46</volume><fpage>888</fpage><lpage>898</lpage><pub-id pub-id-type="pmid">17321637</pub-id></mixed-citation></ref><ref id="pone.0008710-Kucharova1"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kucharova</surname><given-names>S</given-names></name><name><surname>Farkas</surname><given-names>R</given-names></name></person-group><year>2002</year><article-title>Hormone nuclear receptors and their ligands: role in programmed cell death (review).</article-title><source>Endocr Regul</source><volume>36</volume><fpage>37</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">11971750</pub-id></mixed-citation></ref><ref id="pone.0008710-Saelim1"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saelim</surname><given-names>N</given-names></name><name><surname>Holstein</surname><given-names>D</given-names></name><name><surname>Chocron</surname><given-names>ES</given-names></name><name><surname>Camacho</surname><given-names>P</given-names></name><name><surname>Lechleiter</surname><given-names>JD</given-names></name></person-group><year>2007</year><article-title>Inhibition of apoptotic potency by ligand stimulated thyroid hormone receptors located in mitochondria.</article-title><source>Apoptosis</source><volume>12</volume><fpage>1781</fpage><lpage>1794</lpage><pub-id pub-id-type="pmid">17701361</pub-id></mixed-citation></ref><ref id="pone.0008710-Jones1"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>SA</given-names></name><name><surname>Jolson</surname><given-names>DM</given-names></name><name><surname>Cuta</surname><given-names>KK</given-names></name><name><surname>Mariash</surname><given-names>CN</given-names></name><name><surname>Anderson</surname><given-names>GW</given-names></name></person-group><year>2003</year><article-title>Triiodothyronine is a survival factor for developing oligodendrocytes.</article-title><source>Mol Cell Endocrinol</source><volume>199</volume><fpage>49</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">12581879</pub-id></mixed-citation></ref><ref id="pone.0008710-VergaFalzacappa1"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verga Falzacappa</surname><given-names>C</given-names></name><name><surname>Panacchia</surname><given-names>L</given-names></name><name><surname>Bucci</surname><given-names>B</given-names></name><name><surname>Stigliano</surname><given-names>A</given-names></name><name><surname>Cavallo</surname><given-names>MG</given-names></name><etal/></person-group><year>2006</year><article-title>3,5,3&#x02032;-triiodothyronine (T3) is a survival factor for pancreatic beta-cells undergoing apoptosis.</article-title><source>J Cell Physiol</source><volume>206</volume><fpage>309</fpage><lpage>321</lpage><pub-id pub-id-type="pmid">16021636</pub-id></mixed-citation></ref><ref id="pone.0008710-Grant1"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grant</surname><given-names>N</given-names></name></person-group><year>2007</year><article-title>The role of triiodothyronine-induced substrate cycles in the hepatic response to overnutrition: thyroid hormone as an antioxidant.</article-title><source>Med Hypotheses</source><volume>68</volume><fpage>641</fpage><lpage>649</lpage><pub-id pub-id-type="pmid">17023119</pub-id></mixed-citation></ref><ref id="pone.0008710-Messarah1"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Messarah</surname><given-names>M</given-names></name><name><surname>Boulakoud</surname><given-names>MS</given-names></name><name><surname>Boumendjel</surname><given-names>A</given-names></name><name><surname>Abdennour</surname><given-names>C</given-names></name><name><surname>El Feki</surname><given-names>A</given-names></name></person-group><year>2007</year><article-title>The impact of thyroid activity variations on some oxidizing-stress parameters in rats.</article-title><source>C R Biol</source><volume>330</volume><fpage>107</fpage><lpage>112</lpage><pub-id pub-id-type="pmid">17303537</pub-id></mixed-citation></ref><ref id="pone.0008710-Venditti1"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Venditti</surname><given-names>P</given-names></name><name><surname>Di Meo</surname><given-names>S</given-names></name></person-group><year>2006</year><article-title>Thyroid hormone-induced oxidative stress.</article-title><source>Cell Mol Life Sci</source><volume>63</volume><fpage>414</fpage><lpage>434</lpage><pub-id pub-id-type="pmid">16389448</pub-id></mixed-citation></ref><ref id="pone.0008710-Palm1"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palm</surname><given-names>F</given-names></name><name><surname>Onozato</surname><given-names>ML</given-names></name><name><surname>Luo</surname><given-names>Z</given-names></name><name><surname>Wilcox</surname><given-names>CS</given-names></name></person-group><year>2007</year><article-title>Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems.</article-title><source>Am J Physiol Heart Circ Physiol</source><volume>293</volume><fpage>H3227</fpage><lpage>3245</lpage><pub-id pub-id-type="pmid">17933965</pub-id></mixed-citation></ref><ref id="pone.0008710-Wang1"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Gill</surname><given-names>PS</given-names></name><name><surname>Chabrashvili</surname><given-names>T</given-names></name><name><surname>Onozato</surname><given-names>ML</given-names></name><name><surname>Raggio</surname><given-names>J</given-names></name><etal/></person-group><year>2007</year><article-title>Isoform-specific regulation by N(G),N(G)-dimethylarginine dimethylaminohydrolase of rat serum asymmetric dimethylarginine and vascular endothelium-derived relaxing factor/NO.</article-title><source>Circ Res</source><volume>101</volume><fpage>627</fpage><lpage>635</lpage><pub-id pub-id-type="pmid">17673667</pub-id></mixed-citation></ref><ref id="pone.0008710-Nijveldt2"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nijveldt</surname><given-names>RJ</given-names></name><name><surname>Teerlink</surname><given-names>T</given-names></name><name><surname>Siroen</surname><given-names>MP</given-names></name><name><surname>van der Hoven</surname><given-names>B</given-names></name><name><surname>Prins</surname><given-names>HA</given-names></name><etal/></person-group><year>2004</year><article-title>Elevation of asymmetric dimethylarginine (ADMA) in patients developing hepatic failure after major hepatectomy.</article-title><source>JPEN J Parenter Enteral Nutr</source><volume>28</volume><fpage>382</fpage><lpage>387</lpage><pub-id pub-id-type="pmid">15568284</pub-id></mixed-citation></ref><ref id="pone.0008710-Frey1"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frey</surname><given-names>D</given-names></name><name><surname>Braun</surname><given-names>O</given-names></name><name><surname>Briand</surname><given-names>C</given-names></name><name><surname>Vasak</surname><given-names>M</given-names></name><name><surname>Grutter</surname><given-names>MG</given-names></name></person-group><year>2006</year><article-title>Structure of the mammalian NOS regulator dimethylarginine dimethylaminohydrolase: A basis for the design of specific inhibitors.</article-title><source>Structure</source><volume>14</volume><fpage>901</fpage><lpage>911</lpage><pub-id pub-id-type="pmid">16698551</pub-id></mixed-citation></ref><ref id="pone.0008710-Leiper1"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leiper</surname><given-names>J</given-names></name><name><surname>Nandi</surname><given-names>M</given-names></name><name><surname>Torondel</surname><given-names>B</given-names></name><name><surname>Murray-Rust</surname><given-names>J</given-names></name><name><surname>Malaki</surname><given-names>M</given-names></name><etal/></person-group><year>2007</year><article-title>Disruption of methylarginine metabolism impairs vascular homeostasis.</article-title><source>Nat Med</source><volume>13</volume><fpage>198</fpage><lpage>203</lpage><pub-id pub-id-type="pmid">17273169</pub-id></mixed-citation></ref><ref id="pone.0008710-Chobanyan1"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chobanyan</surname><given-names>K</given-names></name><name><surname>Thum</surname><given-names>T</given-names></name><name><surname>Suchy</surname><given-names>MT</given-names></name><name><surname>Zhu</surname><given-names>B</given-names></name><name><surname>Mitschke</surname><given-names>A</given-names></name><etal/></person-group><year>2007</year><article-title>GC-MS assay for hepatic DDAH activity in diabetic and non-diabetic rats by measuring dimethylamine (DMA) formed from asymmetric dimethylarginine (ADMA): evaluation of the importance of S-nitrosothiols as inhibitors of DDAH activity in vitro and in vivo in humans.</article-title><source>J Chromatogr B Analyt Technol Biomed Life Sci</source><volume>858</volume><fpage>32</fpage><lpage>41</lpage></mixed-citation></ref><ref id="pone.0008710-Huang1"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>Ma</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Qatanani</surname><given-names>M</given-names></name><name><surname>Cuvillier</surname><given-names>J</given-names></name><etal/></person-group><year>2006</year><article-title>Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration.</article-title><source>Science</source><volume>312</volume><fpage>233</fpage><lpage>236</lpage><pub-id pub-id-type="pmid">16614213</pub-id></mixed-citation></ref><ref id="pone.0008710-Mayoral1"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayoral</surname><given-names>R</given-names></name><name><surname>Fernandez-Martinez</surname><given-names>A</given-names></name><name><surname>Roy</surname><given-names>R</given-names></name><name><surname>Bosca</surname><given-names>L</given-names></name><name><surname>Martin-Sanz</surname><given-names>P</given-names></name></person-group><year>2007</year><article-title>Dispensability and dynamics of caveolin-1 during liver regeneration and in isolated hepatic cells.</article-title><source>Hepatology</source><volume>46</volume><fpage>813</fpage><lpage>822</lpage><pub-id pub-id-type="pmid">17654701</pub-id></mixed-citation></ref></ref-list><fn-group><fn fn-type="conflict"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding: </bold>This work was supported by grants BFU2008-02161, BFU2007-62402, SAF2007-60511, and SAF2007-60551 from MICINN; S-BIO-0283/2006 from Comunidad de Madrid and FIS-RECAVA RD06/0014/0025 to L.B.; and PI05.0050, PI080070, and the Fundacion Mutua Madrilea to S.H. RECAVA and Ciberehd are funded by the Instituto de Salud Carlos III. R. L-F. is supported by a fellowship from Instituto de Salud Carlos III. The CNIC is supported by the Spanish Ministry of Science and Innovation and the Pro-CNIC Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></fn></fn-group></back></article>